<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72044">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01724242</url>
  </required_header>
  <id_info>
    <org_study_id>DHEA-HMO-CTIL</org_study_id>
    <nct_id>NCT01724242</nct_id>
  </id_info>
  <brief_title>Vaginal DHEA for Women After Breast Cancer</brief_title>
  <official_title>Vaginal DHEA to Ease Vaginal Dryness in Women With a Contraindication to Estrogen Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There does not appear to be a consensus regarding the treatment of vaginal dryness in women
      who have a contraindication to the use of estrogen products. DHEA, when used locally, may
      improve the symptoms of vaginal dryness due to its chemical properties.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>improvement in vaginal dryness</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>improvement in urinary incontinence</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement in sexual satisfaction</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Vaginal Dryness</condition>
  <condition>Breast Cancer</condition>
  <condition>Urinary Incontinence</condition>
  <condition>Quality of Life</condition>
  <condition>Sexual Satisfaction</condition>
  <arm_group>
    <arm_group_label>Vaginal DHEA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vaginal DHEA 0.5%(6.5mg)inserted nightly</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vaginal DHEA</intervention_name>
    <arm_group_label>Vaginal DHEA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women post menopausal aged 35-55, suffering from vaginal dryness, secondary to
             chemotherapy for breast cancer, within 5 years of diagnosis. Follicle Stimulating
             Hormone and Estradiol levels in the post menopausal range are needed.

        Exclusion Criteria:

          -  women using products to alleviate vaginal dryness.

          -  women taking medication for urinary incontinence

          -  women not sexually active, for other reasons.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Drorith Hochner-Celnikier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Drorith Hochner-Celnikier, MD</last_name>
    <phone>00 972 2 5844400</phone>
    <email>hochner@hadassah.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hadas Lemberg, PhD</last_name>
      <phone>00 972 2 6777572</phone>
      <email>lhadas@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>Drorith Hochner-Celnikier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 7, 2012</lastchanged_date>
  <firstreceived_date>November 7, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vaginal dryness</keyword>
  <keyword>Breast Cancer</keyword>
  <keyword>Urinary Incontinence</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Sexual Satisfaction</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dehydroepiandrosterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
